Status:
COMPLETED
ProbioKid as Prevention Among Kids With Frequent URTI
Lead Sponsor:
Lallemand Health Solutions
Conditions:
Respiratory Tract Infections
Eligibility:
All Genders
3-10 years
Phase:
NA
Brief Summary
This study was designed to evaluate the preventive efficacy of a 6-week prophylactic administration of Probiokid® on the incidence of respiratory infections and related complications in frequently sic...
Detailed Description
The microbiota is very important for the development of the immune system in children. Lactic acid bacteria, such as Lactobacillus and Bifidobacterium, are usually administered as probiotics (defined ...
Eligibility Criteria
Inclusion
- Age of children from 3 to 10 years,
- High frequency of acute respiratory tract infections, characterized by a resistance index more than 0.33 (i.e. ARIs more often than once every 3 months).
- Absence of other medications that affect the immune system in the treatment regimen (except for antibiotics, as per the care provider's judgment).
Exclusion
- • Chronic pathological conditions.
Key Trial Info
Start Date :
September 14 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2017
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04525040
Start Date
September 14 2016
End Date
June 25 2017
Last Update
August 25 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.